A range of specialist consultants may be involved in your care at UCLH. These may include neurosurgeons, neurologists, oncologists, neuroradiologists and other types of consultant.
Mr Allibone has a particular interest and expertise in spinal tumours and provides the surgical arm for The London Sarcoma and Primary Bone Tumour service. The tumour service also has links with The Royal Marsden, The Brompton and Mount Vernon Hospitals.
Mr Allibone is a member of The North American Spine Society and The British Association of Spinal Surgeons.
Mr Bradford qualified in 1979 at University College Hospital Medical School followed by house jobs at Addenbrooke's and UCLH. He obtain his FRCS in 1983 following general surgical training. He spent two years conducting research in neuro-oncology at The Institute of Neurology which lead to the award of Doctor of Medicine (MD) in 1987.
He undertook clinical neurosurgical training at The National Hospital for Neurology and Neurosurgery (NHNN) and The Wessex Neurological Centre. He was appointed consultant neurosurgeon at the Royal Free Hospital in 1989 and also honorary consultant neurosurgeon at The Royal National Orthopaedic Hospital, Stanmore.
He is a past Chair Brain/CNS tumour board North London Cancer Network.
As well as an interest in neuro-oncology he has an extensive skull base practice.
Mr Adrian Casey is currently the lead clinician for complex spinal surgery. Mr Casey qualified from Westminster Medical School (Imperial College) in 1985. His neurosurgery training was in Atkinson Morleys Hospital and the National hospital Queen Square, where he did his research with Alan Crockard on the rheumatoid cervical spine.
His first consultant appointment was to Charing Cross Neurosurgery Unit in 1997. He was subsequently appointed as the first spinal neurosurgeon in the UK to his current post at The Royal National Orthopaedic Hospital (RNOH), Stanmore and the National Hospital for Neurology and Neurosurgery (NHNN), Queen Square. This was a specially created post to bring together the two disciplines of spine surgery (Orthopaedics & Neurosurgery).
He is involved with most aspects of complex spine surgery. He was involved in setting up Spinal Training for the European Association of Neurological Surgeons
Professor David Choi trained in general surgery at the Glasgow Royal Infirmary, and underwent specialist neurosurgical training at the Glasgow Institute of Neurological Sciences, Atkinson Morley’s Hospital and the National Hospital for Neurology and Neurosurgery (NHNN), London. He obtained a PhD in neuroregeneration, and was awarded the Hallett Prize medal from the Royal College of Surgeons, London.
His clinical interests include complex spine surgery, spinal tumours, spinal trauma, degenerative spinal conditions, skull base tumours, skull base endoscopy, and craniocervical junction surgery. He holds an academic post at the UCL Institute of Neurology, and was awarded a prestigious research grant from the European Research Council in 2009.
Mr Dorward is a consultant neurosurgeon who performs both cranial and spinal surgery with a particular interest in endoscopic surgery, pituitary region surgery and complex spinal surgery. He specialises in minimal access spinal surgery and disc replacements.
Miss Grieve was appointed consultant neurosurgeon at the National Hospital for Neurology and Neurosurgery (NHNN) in 2002.
Her clinical interests include pituitary and parasellar pathologies; neurovascular treatment for intracranial aneurysms, arteriovenous malformations and cavernous haemangiomas; gamma knife radiosurgery; and neuro-oncology as well as general intracranial neurosurgery.
Miss Grieve was clinical lead for neurosurgery from 2007-2013. During her tenure, she oversaw the amalgamation of neurosurgical services for North Central London (then based at the NHNN and Royal Free Hospitals) into a single service at the NHNN. She also oversaw the opening of the first nationally dedicated brain tumour ward, Molly Lane Fox Brain Tumour Unit; and the provision of a single site pituitary and skull base neurosurgical service for North London at Queen Square.
She is a member of the Society of British Neurosurgeons, the British Neurovascular Group and an international member of the Congress of Neurological Surgeons.
Mr Neil Kitchen is a consultant neurosurgeon at the National Hospital for Neurology and Neurosurgery (NHNN) and lead neurosurgeon for neuro-oncology.
He studied medicine at Bart's Health, University College London Hospitals and at Addenbrooke's Hospital in Cambridge. Before moving to Cambridge he completed a BSc degree in the history of medicine at the Wellcome Institute.
Mr Kitchen has special clinical interest in brain tumour surgery, intracranial microsurgery, trigeminal neuralgia, cavernoma and radiosurgery (Gamma Knife).
Mr Kitchen has also worked at Bart's, Charing Cross Hospital, the Royal Free, Atkinson Morley's, Southend Hospital, and the National Hospital for Neurology and Neurosurgery.
Mr Marcus is an academic consultant neurosurgeon, and was among the first cohort of trainees to be selected for a Walport Integrated Academic Training Pathway, with rotations at the University of Cambridge, Imperial College London, and University College London.
His clinical interest is in “keyhole” endoscopic neurosurgical approaches. To this end, he completed fellowships in endoscopy and anterior skull base surgery (including pituitary surgery) at the Klinik Hirslanden, Zurich and the National Hospital for Neurology and Neurosurgery. His research interest, and the subject of his doctoral thesis under Prof Lord Darzi, is the development and evaluation of new devices that makes these keyhole approaches more safe and effective, including augmented reality, robotics, and artificial intelligence.
Andrew McEvoy is a world-leading consultant neurosurgeon at The National Hospital for Neurology (NHNN) and Neurosurgery and Institute of Neurology (ION).
Listed in The Times 2010 top UK doctors for his epilepsy and brain tumour surgery,
Mr McEvoy’s specialist neuro-oncology service has a particular interest in the prediction and preservation of function during large resective neurosurgical procedures and the reorganisation of brain function around brain tumours. This multidisciplinary approach integrates facilities such as 3T MRI, FMRI for language and motor function, DTI, MEG, neurophysiology and neuropsychology.
As a result of this expertise, he performs probably the largest number of ‘awake’ craniotomies presently in the UK. This enables the largest possible resection of brain tumours while minimalising neurological deficit Gamma Knife and Cyberknife ensure that patients have access to the most extensive treatment options available at any centre throughout the world.
Mr Russo is a Neurosurgeon specialised in Complex Reconstructive Spinal Surgery for Spinal Tumours, Complex Degenerative spinal conditions of the cervical, thoracic and lumbar spine; Spinal Infection, Revision spinal surgery, Spinal trauma and Spinal deformity. He is dually trained in Spinal Neurosurgery and Orthopaedic Spinal Surgery. Following the Neurosurgical training, he completed a post-CCT fellowship in USA, followed by 3 years of advanced complex orthopaedic deformity fellowships. He is a Consultant Spinal Neurosurgeon from 2012.
Mr. Vittorio Russo is a neurosurgeon with interest in complex spine surgery. He has a formal training in neurosurgery with two additional years of dedicated combined complex spine neurosurgery and orthopaedic spine fellowship training. Mr. Russo has also spent two years in the USA for his fellowship in neurosurgery and microsurgical neuroanatomy.
His clinical interests include complex spine surgery, spinal tumours, spinal traumas, degenerative conditions, cranio-cervical junction surgery, minimally invasive spinal surgery.
He is currently the lead clinician for the Acute Spinal Tumour service, including metastatic spinal cord compression (MSCC).
George Samandouras has been trained in Oxford at the Radcliffe Hospitals NHS Trust and has completed a fellowship in Paris in 2008.
At Queen Square he directs the education and training of neurosurgical trainees and fellows.
His clinical interests include brain tumours, minimally invasive surgery and spine surgery. Surgical oncology techniques employed include fluorescent-guided resection, cortical mapping and intraoperative MRI.
Full consultant profile
Miss Sethi is a Consultant Neurosurgeon at The National Hospital for Neurology and Neurosurgery (NHNN).
Training programme director (ST1-ST3) for North Thames Neurosurgical training programme, which is the biggest training rotation in the UK. Her specialist clinical interest include Neuro-oncology, Intraventricular Endoscopy, Radiosurgery (Gamma Knife), Peripheral Nerve Surgery & Degenerative Spine Surgery.
Mr Lewis Thorne is a consultant neurosurgeon at the National Hospital for Neurology and Neurosurgery (NHNN) at Queen Square.
He graduated from Edinburgh University in 1995 and completed his postgraduate training in London, becoming a consultant in 2007. He has a specialist interest in the management of brain tumours, utilizing a range of techniques including: awake surgery, intraoperative MRI, fluorescence guided resection and Gamma Knife. He works in a multidisciplinary clinic offering long term follow up with both surgeon and specialist oncologist, along with a clinical nurse specialist (CNS).
Dr Naomi Fersht coordinates care across brain tumour services at UCLH.
She is a consultant clinical oncologist at University College Hospital and the National Hospital for Neurology and Neurosurgery (NHNN). She specialises exclusively in the management of primary and secondary brain and spinal tumours. This involves the use of both conventional and innovative radiotherapy techniques and chemotherapy.
Her special interests are: brain oligometastases; meningiomas; pituitary tumours; the management of teenagers and young adults with brain tumours (age 16-24); and advanced radiotherapy techniques including radiosurgery.
She qualified from the University of Cambridge and her specialist training was at the Royal Marsden and University College Hospitals. Naomi's doctoral thesis, supervised by Nobel Laureate Sir Paul Nurse, was in cell cycle checkpoints.
Dr Paul Mulholland is a medical oncologist who exclusively treats brain cancer. He is a consultant at University College Hospital, the National Hospital for Neurology and Neurosurgery (part of UCLH) and Mount Vernon Cancer Centre, and he is chair of the HCA Cancer Care brain and CNS tumour board. Dr Mulholland is also an honorary senior lecturer at University College London and a training programme director.
Paul did his doctoral research in genomic profiling in brain cancer at the Cancer Research UK London Research Institute. This led to his focus on developing biomarkers and targets for therapy in brain cancer, including the clinical trial portfolio of novel agents in brain cancer which he now runs at UCLH and nationally.
Dr Kai-Keen Shiu is the clinical lead for the Cancer of Unknown Primary Service, and the Acute Oncology Service at UCLH. He is actively involved in gastrointestinal oncology clinical trial research. He also has a specialist interest in treating patients with cancer of unknown primary, their entry into clinical trials, and management of oligometastatic disease.
Dr Shiu is the Principal Investigator of the UCL / UCLH Gastrointestinal Cancer Translational Research Biobank. He is a chief investigator and principal investigator for a number of national and international trials. He also undertakes early phase clinical trials in the private sector.
Dr Anup Vinayan is a consultant clinical oncologist.
Dr Jeremy Rees was appointed as a consultant neurologist at the National Hospital for Neurology and Neurosurgery (NHNN) in 1999 and has built a national and international reputation in neuro-oncology, seeing patients with brain tumours, particularly low-grade gliomas. His opinion is widely sought on the diagnosis and treatment of neurological problems related to cancer and cancer treatments. He was previously the Director for London Cancer Brain Tumour Pathway Board, involved in systematic improvements to patient pathways in North London.
He has been Education Lead for Neurology at UCL Medical School and is currently the Lead for the Special Study Module in Neurology. He lectures widely to different professional groups and has written chapters and a textbook in Neuro-oncology. He was the Chief Investigator for the UK in a major European trial of treatment options in Low Grade Gliomas.
Dr Gary Hotton qualified from University College and Middlesex School of Medicine in 1995. His general medical training was undertaken at Dundee Royal Infirmary and the Royal Free Hospital. Following this he spent seven years in research at Kings College Hospital and Imperial College. He then returned to specialist training in London and joined the specialist register in May 2010.
Dr Hotton is a consultant neurologist and divides his time between the National Hospital for Neurology and Neurosurgery (NHNN) and The North Middlesex Hospital. At the NHNN he has a specialist neuro-oncology clinic and is a core member of the neuro-oncology multidisciplinary team.
At the North Middlesex Hospital he provides an in-patient and out patient general neurology service.
Ear, Nose and Throat (ENT) Surgeons
Mr Peter Andrews, Consultant ENT and Head and Neck Surgeon, was appointed to the Royal National Throat Nose and Ear Hospital in 2005. He has a sub speciality interest in Rhinology and Facial Plastic Reconstructive Surgery.
His main clinical areas of interest include nasal airway reconstruction and facial reanimation surgery. He has co-designed and implemented a tertiary referral facial function clinic at the RNTNEH.
He has an expanding interest in sinonasal neoplasia and other aspects of anterior skull base surgery. He is an Honorary Consultant Surgeon at the National Hospital for Neurology and Neurosurgery (NHNN) and is an active member of its monthly skull base MDT.
Mr Sherif Khalil completed his higher surgical training in the North Thames region in London in all aspects of elective and emergency otolaryngology. He has trained in different centres of excellence such as Charing Cross, The Royal National Throat, Nose and Ear, The National Hospital for Neurology and Neurotology (NHNN) and the Northwick Park Hospitals.
He has experience in all aspects of surgery of the ear, nose and throat and is a lateral skull base surgeon at the NHNN.
Mr Rupert Obholzer is an ENT consultant specialising in disorders and surgery of the ear, skull base, facial nerve and parotid gland.
Professor Saeed graduated from King’s College, London and has been a consultant ENT and skullbase surgeon in Manchester Royal Infirmary and Hope Hospital until his present Professorial appointment in London. He also holds honorary appointments at University College Hospital, King’s College Hospital, Guy’s Hospital as well as St George’s Hospital in London.
He has extensive experience in lateral skullbase surgery as well as implantation otology and has published prolifically on these topics. He undertakes peer review as well as serves on the editorial board for numerous international journals. He is enthusiastically active in otological research and currently holds £1.5 Million in research grants.
Dr Miszkiel has been a consultant at The National Hospital for Neurology and Neurosurgery since 1998.
Tarek Yousry is professor of neuroradiology at UCL Institute of Neurology, head of Lysholm Department of Neuroradiology, National Hospital for Neurology & Neurosurgery, and Head of the Division of Neuroradiology and Neurophysics. He was awarded the Fellowship of the Royal College of Radiologists in 2003.
Dr Stephanie Baldeweg is the Clinical Lead at the Department of Diabetes and Endocrinology at UCLH. She works as a Consultant Physician in Diabetes and Endocrinology and as Honorary Senior Lecturer at UCL.
Stephanie is interested in all aspects of diabetes and endocrinology. She has a special clinical and research interest in pituitary disease and late effects of cancer on the endocrine system. Her other interests include diabetes, thyroid and reproductive disease as well as osteoporosis, weight management and cardiovascular risk reduction.
Stephanie regularly lectures at national and international meetings as well as patient days for UK charities. She is a trustee of The Pituitary Foundation.
Professor Bouloux is a general endocrinologist and internist with special interest in neuroendocrinology and andrology.
A Haem-oncologist is a doctor who specialises in the treatment of patients with lymphoma in the brain. The different treatment strategies include chemotherapy, immunotherapy, radiotherapy and haematopoietic stem cell transplantation.
This care is based at University College Hospital and the University College Hospital Macmillan Cancer Centre.
Sebastian Brandner is Professor of Neuropathology at UCL and Honorary Consultant Neuropathologist at the National Hospital for Neurology and Neurosurgery (NHNN) at UCLH. He leads the Division of Neuropathology and is specialised in brain tumour diagnostics including molecular diagnostics, and neurodegeneration.
He has authored and co-authored research publications on brain tumour models, book chapters in major neuropathology textbooks, and the 2016 WHO classification as well as guidelines for the Royal College of Pathologists. He serves on the National Institute of clinical excellence (NICE) guideline committee to establish guidelines for management and treatment of primary brain tumours and cerebral metastases
The Division of Neuropathology receives brain tumour referrals from the NHNN, and several major regional hospitals. The Division also provides a molecular pathology service for referrers across the United Kingdom.
Dr Maria Thom has been working in the department of Neuropathology at the National Hospital (NHNN) as an honorary consultant since 1996. Her main main diagnostic and research interests are in the field of epilepsy neuropathology. In general aspects the neurobiology of hippocampal sclerosis, cortical malformations, low-grade tumours and altered neurogenesis in patients undergoing surgical treatment for epilepsy.
Maria is a member of the Professional Affairs Committee of the BNS, audit lead for neuropathology and an ILAE task force member.